Eli Lilly and Company - Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin
Links shared publicly online about this topic.
- 634total visits
Eli Lilly and Company - Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin
Eli Lilly and Company - Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin
View full resource at investor.lilly.com
Tags: Diabetes Type 2 Medication, Diabetes Medication, Insulin, Byetta, Eli Lilly and Company
Most Recently Shared on December 23, 2010 at 1:29 pm By:
Lilly and Amylin file sNDA for Byetta seeking expansion of indication http://ow.ly/3tEr9
Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
newsroom.lilly.com — “Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes” View full resource at newsroom.lilly.com
Most Recently Shared on November 1, 2009 at 3:10 pm By:
eyeonfda Pharma and Health Lawyer
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes - http://bit.ly/3SxCxX
Advertisement
